
|Articles|February 1, 2004
Industry lobbyists shift focus to state houses
State efforts to curb costs range from medical liability and tort reform to mandated benfits
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Researchers discover new pathway to fight liver inflammation
2
FDA approves $2.7 million gene therapy for rare metabolic disorder
3
BE BOLD Efficacy and Safety Data: Comparing Bimekizumab and Risankizumab on Joint-Centric Endpoints
4
Overlooked bladder nerves now thought to reduce UTI burden through pain signaling, study shows
5






















